期刊文献+

端粒重复扩增-微孔板杂交法检测妇科肿瘤端粒酶活性的研究 被引量:1

STUDY OF THE TELOMERASE ACTIVITY IN GYNECOLOGIC CARCINOMAS USING TELOMERE REPEAT AMPLIFICATION-MICROWELL PLATE HYBRIDIZATION
下载PDF
导出
摘要 目的 :探讨妇科几种常见恶性肿瘤与端粒酶活性的关系。方法 :采用端粒重复扩增 (TRAP)扩增端粒酶产物 ,通过生物素 -亲和素将扩增产物结合于微孔板 ,并与荧光素 (FITC)标记的特异性探针杂交 ,经酶标抗荧光素抗体结合而显色。结果 :妇科恶性肿瘤端粒酶活性检出 2 5例 (89.3% ) ,而肿瘤边缘组织检出 14例 (5 0 .0 % ) ,正常对照组织检出 10例 (35 .7% )。恶性肿瘤端粒酶活性显著高于肿瘤远端组织和正常对照组织 (P<0 .0 5 )。结论 :端粒酶激活可能在妇科恶性肿瘤的发生、发展中起重要作用。 TRAP-微孔板杂交法是检测端粒酶活性灵敏而特异的一种方法。 Objective:To investingate the relationship between telomerase activities and some common gynecologic carcinomas.Method:Telomerase activities were measured by the telomere repeated amplification protocol(TRAP)-microwell plate hybridization system.Result:Telomerase activities in gynecologic carcinomas were found by 89.3% (25/28),in the margin tissues between carcinoma and normal 50% (14/28) and in normal tissues only 35.7%(10/28).Telomerase activities in gynecologic carcinomas were significantly higher than in the margin and normal tissues(P<0 05).Conclusion:Activation of telomerase may play an important role in gynecologic carcinomas.TRAP-microwell plate hybridization system is a specific and sensitive assay to detect the telomerase activity. [
出处 《南通医学院学报》 2002年第3期264-265,共2页 ACTA Academiae Medicinae Nantong
关键词 端粒重复扩增-微孔板杂交法 妇科肿瘤 端粒酶活性 Telomerase Carcinoma of cervix uteri Epithelial ovarian tumor Carcinoma of endometrium Telomere repeated amplification protocol-microwell plate hybridization
  • 相关文献

参考文献4

  • 1Feng J;Funk WD;Wang SS.The RNA component of human telomerase[J],1995(5228).
  • 2Broccoli D;Young JW;de-Lange T.Telomerase activity i n normal and malignant hematopoietic cells,1995(92).
  • 3Rhyu MS.Telomeres,Telomerase,and immortality[J],1995(12).
  • 4Kim NW;Piatyszek MA;Prowse KR.Specific association of human telomerase activity with immortal cells and cancer[J],1994.

共引文献12

同被引文献8

  • 1Yoshida K,Sugino T,Tahara H,et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine[J]. Cancer, 1997,79 (2): 362-369.
  • 2Ramakumar S,Bhujyan J,Besse J A,et al. Comparison of screening methods in the detection of bladder cancer. J Urol, 1999,161 : 388-394.
  • 3Shay JW. Telomerase and clinica Applications. Proceedings of the American Association for cancer Rescarch,1997,38: 658-659.
  • 4Kim NW,Piatyszek MA,Prowse KR,et al. Specific association of human telomerase activity with immortal cells and canc er[J ]. Science, 1994,266 : 2011 - 2015.
  • 5Muller Markus. Telomerase: its clinical relevance in the diagnosis of bladder cancer. Oncogene, 2002, 21 (4): 650-655.
  • 6Saad A, Hanbury DC, McNicholas TA, et al. A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU- Iht, 2002, 89 (4) : 369 -373.
  • 7Kitsukawa SI,Ohyashiki K,Yahata N,et al. Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection. IntJ Oncol, 1999,15(3) :505-510.
  • 8卫立辛,郭亚军,闫振林,施军霞,沈锋,谢天培,崔贞福,吴孟超.检测人端粒酶活性的端粒酶TRAP-ELISA法的建立[J].中华肿瘤杂志,1998,20(4):264-266. 被引量:53

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部